(bempedoic acid + ezetimibe + rosuvastatin)
Preclinicalupdated 2mo agoby $ESPR Esperion Therapeutics, Inc.
Preclinicalcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
nothing on the calendar yet
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that